Home » Topics » Inflammatory, BioWorld Science

Inflammatory, BioWorld Science
RSS

Pliant Therapeutics patents new integrin alphavbeta1 antagonists

April 5, 2018

Genentech and Roche present new HsNIK inhibitors

March 22, 2018

Institut Pasteur de Montevideo and Universidad de la Republica describe new trolox derivatives

March 21, 2018

Lycera patents new Rho-associated protein kinase 1/2 inhibitors

March 19, 2018

New polynucleotides encoding semaphorin-6 synthesized at Kanazawa University

March 8, 2018

Novel NF-kappaB inhibitors synthesized at University College Dublin

March 8, 2018

CYP11A1 expression identifies anaphylaxis risk in children with peanut allergy

March 5, 2018

Bristol-Myers Squibb presents phase Ib data for anti-PD-L1 BMS-936559 in sepsis

March 1, 2018

Accro Bioscience divulges necrosis inhibitors

Feb. 16, 2018

Galecto Biotech discovers galectin inhibitors

Feb. 1, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
Coreterra Therapeutics patents agents for schizophrenia
BioWorld Science
Work at Coreterra Therapeutics Inc. has led to the discovery of new thienyl compounds intended for potential use in the treatment of schizophrenia.